From early on during the COVID-19 pandemic, many potential drug therapies became and remain controversial. The various medications in this article may include both effective and ineffective treatments of the SARS-CoV-2 virus and the resulting COVID-19 disease state. The primary purpose is to categorize and summarize those treatments here.
Hundreds of studies on dozens of drugs used during the COVID-19 pandemic are documented and summaried at www.c19study.com.
While antidepressants may not seem like the most important class of repurposed drugs, COVID-19 is a unique disease, and it may not always be clear what biochemical influences might help some of those affected fight off the disease.
An antiviral agent is any agent that works as an antiviral, and may or may not otherwise be ordinarily recognized as a drug or have other medical uses.
See also zinc ionophores
Since clotting is among the most damaging symptoms of COVID-19, numerous anticoagulants have been used by some doctors.
An in silico study showed that enfuvirtide can act as a potent SARS-CoV-2 fusion inhibitor.1)
Many COVID-19 vaccines have been deployed with others in the development pipeline.
Many vitamins, minerals, and nutraceutical supplements have been proposed, tested, or used in the treatment of SARS-CoV-2 and COVID-19.
Many medical doctors have shared the results of multidrug treatment protocols that they have used with patients in their practice.
| Protocol Name | # of patients treated | # of patients hospitalized | # of patients died | Case Fatality Rate |
|---|---|---|---|---|
| Dr. Syed Haider IVM + FLV2) | 4,000+ | 5 | 0 | 0 |
| Zelenko High Risk Patient Protocol 3) | 141 | 4 | 1 | 0.7% |
| Tyson Farid mild | 7,000 | 2 | 0 | 0 |
| Tyson Farid moderate4) | 413 | 7 | 3 | 0.7% |
| Italy Protocol | 66,000 | ? | 4 | 0.00606% |
| Chetty 8th Day Therapy 5) 6) | 4,000 | |||
| Demello 7) | 10,000+ | ?? | ?? | ?? |
Dr. Peter McCullough has also developed early outpatient treatment protocols, publishing his findings at the end of 2020 and beginning of 2021: https://pubmed.ncbi.nlm.nih.gov/33387997/ https://pubmed.ncbi.nlm.nih.gov/32771461/